Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Who this might be right for
Neoplasms
GlaxoSmithKline 34